{"company": {"org_id": "T000295159", "org_name_cn": "上海泓博智源医药股份有限公司", "org_short_name_cn": "泓博医药", "org_name_en": "Pharma Resources (Shanghai) Co.,Ltd.", "org_short_name_en": "PR", "main_operation_business": "药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。", "operating_scope": "　　新药及相关生物技术的研究、开发、自有技术转让，提供相关技术服务和咨询（依法须经批准的项目，经相关部门批准后方可开展经营活动）。", "district_encode": "310115", "org_cn_introduction": "上海泓博智源医药股份有限公司的主营业务是药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。公司的主要产品是药物发现、工艺研究与开发、商业化生产。公司新申请专利14项，其中发明专利7项，实用新型7项。截至报告期末，公司已获得43项国内外专利授权，其中国内授权专利42项，美国授权专利1项，取得软件著作权1项。", "legal_representative": "陈平", "general_manager": "陈平", "secretary": "李秋丽", "established_date": 1197561600000, "reg_asset": 139586605.0, "staff_num": 1004, "telephone": "86-21-50720100", "postcode": "201201", "fax": "86-21-50720097-266", "email": "info@pharmaresources.cn", "org_website": "www.pharmaresources.cn", "reg_address_cn": "上海市浦东新区庆达路315号23幢", "reg_address_en": null, "office_address_cn": "上海市浦东新区凯庆路59号12幢", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1667232000000, "provincial_name": "上海市", "actual_controller": "安荣昌 (7.67%)，陈平 (7.33%)，蒋胜力 (5.67%)", "classi_name": "其他", "pre_name_cn": null, "chairman": "陈平", "executives_nums": 16, "actual_issue_vol": 19250000.0, "issue_price": 40.0, "actual_rc_net_amt": 685848400.0, "pe_after_issuing": 43.78, "online_success_rate_of_issue": 0.02175461, "affiliate_industry": {"ind_code": "BK0075", "ind_name": "医疗服务"}}}